Blue Cross and Blue Shield of Illinois has named the first cohort of early-stage start-ups to participate in the BCBSIL Innovation Accelerator program. BCBSIL has teamed up with MATTER, a Chicago-based global healthcare incubator and corporate innovation accelerator, to identify solutions to influence healthcare beyond the doctor’s office amid the in the crisis of COVID-19.
- Accelerator program: As part of the accelerator program, each company will be awarded a payment of $25,000 to help further refine and scale their solution based on pre-defined key performance indicators. Additionally, over the three months, the teams will benefit from curriculum offerings provided by MATTER, BCBSIL mentorship and subject matter expertise from BCBSIL senior leaders.
- Alimus: Alimus’ mission is to lower overall birth-related health care costs by providing birth doula services to expecting mothers, including prenatal, labor, and immediate postnatal support. Alimus’ goal is to reduce adverse birth outcomes and facilitate a healthier and safer pregnancy and birth experience for families.
- Compris: Compris introduces the first comprehensive addiction diagnostics and risk-stratification assessment, prevention, and treatment guide consistent with a chronic illness paradigm. Patients complete an online, 15- to 30-minute self-report that securely delivers the Compris Profile© to providers within minutes. Compris’ fully automated, HIPAA-compliant, timely needs assessment helps mitigate the ongoing addiction epidemic.
- Medsense Health: Medsense Health is a medication management and remote monitoring platform that helps people safely and effectively adhere to their medication regimen using attachable Bluetooth sensors and a mobile application.
- Delivery solutions: “BCBSIL has picked three great companies — each one a promising, early-stage MATTER portfolio company poised to make real change to benefit patients and families” said Steven Collens, CEO of MATTER. “These innovative new care delivery solutions will help expecting mothers, people battling substance use disorders and seniors or others managing medication schedules.”
